Literature DB >> 27090935

Allergen immunotherapy: No evidence of infectious risk.

Diana S Balekian1, Aleena Banerji1, Kimberly G Blumenthal1, Carlos A Camargo2, Aidan A Long3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27090935      PMCID： PMC5075241          DOI： 10.1016/j.jaci.2016.03.021

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Allergen immunotherapy: a practice parameter third update.

Authors:  Linda Cox; Harold Nelson; Richard Lockey; Christopher Calabria; Thomas Chacko; Ira Finegold; Michael Nelson; Richard Weber; David I Bernstein; Joann Blessing-Moore; David A Khan; David M Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher Randolph; Diane E Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2010-12-03       Impact factor: 10.793

Review 2.  Allergic rhinitis.

Authors:  Richard W Weber
Journal:  Prim Care       Date:  2008-03       Impact factor: 2.907

3.  Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data.

Authors:  Adrian G Letz; Michael S Tankersley; John P Dice; Ronald W England
Journal:  J Allergy Clin Immunol       Date:  2009-02-28       Impact factor: 10.793

Review 4.  Clinical practice. Allergic rhinitis.

Authors:  Lisa M Wheatley; Alkis Togias
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

5.  Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.

Authors:  Daniel J Pallin; Janice A Espinola; Donald Y Leung; David C Hooper; Carlos A Camargo
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

6.  Allergen vial mixing and immunotherapy: Risks of infections and vial contamination.

Authors:  P Chase Lay; Richard Bass; Sandra Y Lin
Journal:  Otolaryngol Head Neck Surg       Date:  2007-08       Impact factor: 3.497

7.  Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections.

Authors:  Kurt B Stevenson; Yosef Khan; Jeanne Dickman; Terri Gillenwater; Pat Kulich; Carol Myers; David Taylor; Jennifer Santangelo; Jennifer Lundy; David Jarjoura; Xiaobai Li; Janice Shook; Julie E Mangino
Journal:  Am J Infect Control       Date:  2008-04       Impact factor: 2.918
  7 in total
  2 in total

1.  Mining social media data to assess the risk of skin and soft tissue infections from allergen immunotherapy.

Authors:  Kimberly G Blumenthal; Maxim Topaz; Li Zhou; Tyler Harkness; Roee Sa'adon; Ofrit Bar-Bachar; Aidan A Long
Journal:  J Allergy Clin Immunol       Date:  2019-02-02       Impact factor: 10.793

2.  COVID-19 pandemic and allergen immunotherapy-an EAACI survey.

Authors:  Oliver Pfaar; Ioana Agache; Matteo Bonini; Helen Annaruth Brough; Tomás Chivato; Stefano R Del Giacco; Radoslaw Gawlik; Aslı Gelincik; Karin Hoffmann-Sommergruber; Marek Jutel; Ludger Klimek; Edward F Knol; Antti Lauerma; Markus Ollert; Liam O'Mahony; Charlotte G Mortz; Oscar Palomares; Carmen Riggioni; Jürgen Schwarze; Isabel Skypala; María José Torres; Eva Untersmayr; Jolanta Walusiak-Skorupa; Adam Chaker; Mattia Giovannini; Enrico Heffler; Erika Jensen-Jarolim; Cristina Quecchia; Mónica Sandoval-Ruballos; Umit Sahiner; Vesna Tomić Spirić; Montserrat Alvaro-Lozano
Journal:  Allergy       Date:  2021-08-25       Impact factor: 14.710
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.